Results 221 to 230 of about 11,852 (296)

Marketing features of derived intoxicating cannabinoid product brands on Instagram: A content analysis

open access: yesAddiction, EarlyView.
Abstract Background and aims Use of derived intoxicating cannabinoid products (DICPs) has grown in the United States (US), as have associated poisonings, emergency department visits and psychotic episodes. Brand marketing on social media, a largely underregulated marketing channel, may be contributing to this growth.
Kathryn La Capria   +10 more
wiley   +1 more source

Network analysis of influential risk factors in adolescent suicide attempters. [PDF]

open access: yesChild Adolesc Psychiatry Ment Health
Fernandez-Fernandez J   +22 more
europepmc   +1 more source

Towards the implementation of cannabis‐focused apps in early intervention services for psychosis: A qualitative investigation of patient and clinician perspectives

open access: yesAddiction, EarlyView.
Abstract Background and aims Cannabis use is highly prevalent among young adults with first‐episode psychosis (FEP) and is associated with poorer clinical and functional outcomes. Mobile health interventions may help address structural barriers to delivering cannabis‐focused psychosocial interventions within early intervention services (EIS), yet ...
Selim Abou‐Rahal   +8 more
wiley   +1 more source

Joint associations of recovery capital and polygenic risk with electronic health record observed remission and relapse in substance use disorder: Longitudinal evidence from the All of Us research program

open access: yesAddiction, EarlyView.
Abstract Background and aims Recovery capital and genetic liability may be related to substance use disorder (SUD) remission through psychosocial and biologic pathways, but their joint association with remission course remains poorly understood. This question is clinically important because people entering remission differ in recovery resources and ...
Janaka V. Kosgolla, Douglas C. Smith
wiley   +1 more source

Concurrent availability of cannabinoid and tobacco products in licensed tobacco retailers in three U.S. cities. [PDF]

open access: yesInt J Drug Policy
Spillane TE   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy